Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA)

166 filings reported holding DNA - Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share as of Q3 2024.
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.3M shares of 48.3M outstanding shares and own 54.48% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (3.58M shares), BAILLIE GIFFORD & CO (3.36M shares), VANGUARD GROUP INC (2.61M shares), Anchorage Capital Group, L.L.C. (1.75M shares), Legal & General Group Plc (1.43M shares), BlackRock, Inc. (1.09M shares), D. E. Shaw & Co., Inc. (873K shares), Opaleye Management Inc. (820K shares), TWO SIGMA ADVISERS, LP (807K shares), and TWO SIGMA INVESTMENTS, LP (659K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.